Inhibition of TNF-α Improves Indomethacin-Induced Enteropathy in Rats by Modulating iNOS Expression
- 108 Downloads
TNF-α, including other proinflammatory cytokines alone or in combination, induces iNOS expression and upregulates inflammatory responses. We evaluated the relationship between TNF-α and iNOS expression in indomethacin-induced jejunoileitis in male Sprague–Dawley rats. Rats were fed a daily dose of a phosphodiesterase inhibitor—either theophylline or pentoxifylline—for 2 days. Jejunoileitis was induced with two subcutaneous injections of indomethacin (7.5 mg/kg) 24 hr apart and theophylline or pentoxifylline continued for 12 hr or 4 days. Other rats received a single intraperitoneal injection of anti-TNF-α monoclonal antibody (TNF-Ab) 30-min before indomethacin. At 4 days TNF-Ab, theophylline, or pentoxifylline treatment significantly decreased indomethacin-induced ulceration, myeloperoxidase activity, and disease activity index. Although indomethacin significantly increased serum TNF-α and nitrate/nitrite levels over the control value as early as 12 hr, iNOS expression was detected only after 4 days. Serum IL-1β level did not change at 12 hr but increased fourfold at 4 days. Treatment with TNF-Ab, theophylline, or pentoxifylline significantly reduced serum/tissue TNF-α, IL-1β, nitrate/nitrite, and iNOS expression. The downregulation of nitrate/nitrite by these inhibitors suggests that TNF-α modulates iNOS expression.
Keywordsanti-TNF-α antibody phosphodiesterase inhibitor nitric oxide synthase intestinal ulceration
Unable to display preview. Download preview PDF.
- 4.Harendra de Silva DG, Mendis LN, Sheron N, Alexander GJM, Candy DCA, Chart H: Concentrations of interleukin G and tumor necrosis factor in serum and stools of children with Shigella dysenteriae 1 infection. Gut 36:194–198, 1993Google Scholar
- 7.Grisham MB, Pavlick KP, Laroux FS, Hoffnan J, Bharwani S, Wolf RE: Nitric oxide and Chronic Gut Inflammation: Controversies in inflammatory bowel disease. J Invest Med 50:272–283, 2002Google Scholar
- 8.Baeverle PA, Baltimore D: NF-KB: Ten years after. Cell 87:13–20, 1996Google Scholar
- 12.Miller MJS, Thompson JH, Zhang XJ, Sadowska-Krowica H, Kakkis SL, Munshi UK, Sandoval M, Rossi JL, Eloby-Childress S, Beckman JS, Ye YZ, Rodi CP, Manning PT, Currie MG, Clark DA: Role of inducible nitric oxide synthase expression and peroxynitrite formation in guinea pig ileitis. Gastroenterology 109:1475–1483, 1995PubMedGoogle Scholar
- 13.Miller MJS, Sandoval M: Nitric oxide III. A molecular prelude to inflammation. Am J Physiol 226 (Gastrointest Liver Physiol 39):G795–G799, 1999Google Scholar
- 14.Grisham MB, Jourd Hevil D, Wink DA: Nitric oxide: I. Physiological chemistry of nitric oxide and its metabolites: implications in inflammation. Am J Physiol 276 (Gastrointest Liver Physiol 39):G315–G321, 1999Google Scholar
- 15.Spatafora M, Chiappara G, Merendino AM, D’Amico D, Bellia V, Bonsignore G: Theophylline suppresses the release of TNF- α by blood monocytes and alveolar macrophages. Eur Resp J 7:223–228, 1994Google Scholar
- 22.Katz J, Willis J, Cooper G, Geraci K, Fiocchi C: Treatment of Crohn’s disease with pentoxifylline: Lack of correlation between clinical improvement and mucosal cytokine levels. Am J Gastroenterol 94:9(abstr 270), 1999Google Scholar
- 24.Spies M, Chappeli VL, Dasu MR, Herndon DN, Thompson JC, Wolf SE: Role of TNF-α in gut mucosal changes after severe burn. Am J Physiol 283 (Gastrointest Liver Physiol 46):G703–G708, 2002Google Scholar
- 27.Totsuka T, Kanai T, Uraushihara K, Iiyama R, Yamazaki M, Akiba H, Yagita H, Okumura K, Watanabe M: Therapeutic effect of anti-OX40L and anti-TNF-α MAbs in a murine model of chronic colitis. Am J Physiol 284 (Gastrointest Liver Physiol 47):G595–G603, 2003Google Scholar
- 28.Nandi J, Saud B, Palma DT, Levine RA: 5-Aminosalicylic acid (5-ASA) improves indomethacin (INDO)-induced enteropathy by inhibiting iNOS transcription in rats. FASEB J 17:A659, 2003 (abstr)Google Scholar